Skip to main content
Premium Trial:

Request an Annual Quote

Mizuho Downgrades Waters to Neutral on Pharma Concerns

NEW YORK (GenomeWeb News) – Investment firm Mizuho today downgraded Waters, citing "choppiness around the pharmaceutical market" that may cause the company's stock to "languish."

Analyst Peter Lawson downgraded Waters to Neutral from a Buy rating but maintained the $110 price target on the company's shares.

In a research note, he said that a year ago he upgraded Waters based on what he viewed as an improving pharmaceutical end market. Pharma revenues comprise about 55 percent of Waters' total revenues, Lawson said. Recently, though, pharma has softened, and in a Mizuho survey released also today, the pharma sector showed "a marked drop in sentiment, along with decreased expectations in funding and spending."

He noted, in particular, Merck's recent announcement of 8,500 additional layoffs and a targeted $2.5 billion in cost reductions.

Waters likely will see mid-single digit growth in consumables, but Lawson was more cautious on instrument revenue growth, which is needed to lift overall revenue growth to the mid-single digits. On a positive note, he said that the company faces easy year-over-year comparisons for the second half of 2013, and share repurchases could increase the bottom line.

In early Monday trading on the New York Stock Exchange, shares of Waters were down around 1 percent at $103.16.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.